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Review: 
Triterpenoid saponins from Cortex Albiziae 
KUN ZOU* AND YUYING ZHAO 
ABSTRACT 
Cortex Albiziae, the dried stem bark of a leguminous plant, Albizia julibrissin Durazz, was specified in Chinese 
Pharmacopoeia (1995 edit.) as a traditional Chinese medicine to be used.to relieve melancholia and uneasiness of body 
and mind, to invigorate the circulation of blood and subside a swelling.1 In a course of our quality assessment of traｭ
ditional Chinese medicines, the n・BuOH soluble part of 95% EtOH extracts from the stem barks of Albizia julibrissin 
was subjected to a series of solvent treatment and chromatographic separations, including Rp-HPLC methods, giving 
rise to 28 pentacyclic triterpenoid saponins. Based on chemical methods and spectroscopic evidences, the structures of 
saponins were identified, which included six pairs of diastereoisomer~ ， five pairs of position isomers, and 26 of them 
were new compounds. All the saponins are 仕isdesmosidic saponins, which are composed of an acacic acid moiety, 7・9
monosaccharide moieties, '1-2 monoterpenic acid moieties, and exhibited their molecular ion peaks around ml左 2000.
Their carbon-13 signals and most of proton signals were assigned based on 1 D and 2D NMR experiments. The proton 
and carbon signals of several known saponins were revised and reassigned. The spectroscopic properties related to 
these saponins were analyzed and summarized. The cytotoxic activity and other activities of these saponins and their 
analogues were discussed also. 
INTRODUCTION 
Saponins are widely distributed in plant spe". 
cies, being reported in nearly 100 families. They are 
naturally occurring glycosides which are found 
mainly, but not exclusively (lower marine animals) 
in the plant kingdom. They consist of aglycone couｭ
plea to sugar chain units. These sugars can be at・
tached ｷas one, two or three sugar chains and the 
terms monodesmoside, bidesmoside and tridesmoside 
have been given to these saponins, respectively. 
According to the na知re of the ｷ aglycone, they can 
be classified into steroidal or triterpene groups. All 
classes of aglycones may have a number of 白nc­
tional groups (usually -OH, -COOH and -CH3, 
some instances -S03Na in marine creatures) causｭ
ing big natural diversity only because of aglycone 
structures. Over 100 steroidal and probably even 
larger numbers of triterpene sapogenins have been 
identified. 2 This diversity can be further multiplied 
by the composition of sugar chains, sugar nl,lmbers, 
branching pa抗ems and type of substitutions. It is 
well .recognized 、 that even one plant species may 
possess a number of individual saponins, e.g., alｭ
falfa roots contain at least 25 medicagenic acid, 
hederagenin, zanhic acid, soyasapogenol and 
bayogenin glycosides, with the attached number of 
sugars ranging 企om one to seven. 3 These structures 
and their amounts may differ depending on the 
plant part studied. This structural diversity and reｭ
sulting wide range of polarities makes fine purificaｭ
tion and preparation of individual saponins very 
difficult, and structural elucidation much compliｭ
cated. 
Man has relied on plants as a source of mediciｭ
nal agents for centuries. Today, with the specter of 
antibiotic resistance, emerging infectious diseases, 
and cancers, phytochemicals continue to provide 
new structural leads for the chemptherapeutic inｭ
dustry. A number of triterpenoids have shown 
promise as antineoplastic agents. Members of the 
cycloartane, lupane, ursane, oleanane, friedelane, 
dammarane, cucurbitacin, and limonoid triterpenoids, 
have demonstrated anti-proliferative activity on 
*Visiting Professor, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Toyama 930・0194,
Japan, and Professor, College of Chemis仕yand Life Science, China Three Gorges University, Yichang 443000, China. 
Email: kzou@ctgu.edu.cn 
4 
various cancer cel lines.4 Saponins are common in 
a large number of plants and plant products that are 
important in human and animal nutrition. Several 
biological effects have been ascribed to saponins. 
Extensive research has been ’ carried out into the 
membrane-permeabilising, immunostimulant, hypoｭ
cholesterolaemic and anticarcinogenic properties of 
saponins and they have also been found to signifiｭ
cantly affect growth, feed intake and reproduction 
in animals. These structurally diverse compounds 
have also been observed to kil protozoans and molｭ
lusks, to be antioxidants, to impair the digesfam of 
protein and the uptake of vitamins and minerals in 
the gut, . tocause hypoglycemia, and to act as 
antifungal and antiviral agents. These c<;>mpounds 
can thus affect animals in a host of different ways 
b~th positive and negative. 5 
Over the centuries, traditional Chinese mediｭ
cines (TCM) have served as a m司or source of 
medicines for the prevention and 仕eatment of disｭ
eases. They uses a system of categorizing clusters 
of symptoms and signs to differe_ntialiy assess the 
presence or absence of syndromes for which effecｭ
tive herbal formulas and methods are known. This 
system can be useful in detecting and counteracting 
some of the severe systemic and metabolic imbalｭ
ances. 6 Interest in TCM isgrowing rapidly beyond 
China. This interest is driven by a combination of 
factors including recognition of potential benefits of 
TCM; dissatisfaction with the traditional W estem 
medical model; an increasing commitment to holisｭ
tic care and increasing evidence for the interaction 
of psychological factors and outcomes of disease 
and 甘eatmentｷ and health consumer demand. 7 A 
brief survey on some reputed traditional Chinese 
medicines demonstrate that saponins are important 
principles responsible for their bioactivities, such as 
ginsenosides in Radix Ginseng,8ｷ 9.glycy町hizin in 
Radix Glycyrrhizae, 10 astragalosides in Radix 
Astragali, 1onjisaponins in Radix. Polygalae, 12and 
saikosaponins in Radix Bupleuri, 13 etc. 
Cortex Albiziae ｷis the dried stem bark of 
Albizia julibrおsin Durazz (Leguminosae ),which is 
known as silk tre, mimosa, silky acacia, and 
Hehuan in Chinese, usually cultivated as an 
ornamental plant in China and Japan, also in the 
southeastern United States and Europe since the 
18th century. Albizia species belongs to Mimosa· ‘ 
subfamily of Leguminosae. Approximate 150 
Albizia species are distributed al over the world 
and 16 of them grow in China,14ｷ 15 The major spe.,. 
cies dis仕ibuted in China ip.clude A. julibrissin 
Durazz., A. chinensis (0) Mert., and A. lebbeck (L) 
Benth. The diied stem barks of A. julibrissin 
Durazz were recorded in Chinese Pharmacopoeia as 
a sedative agent to dispel melancholy and soothe 
the nerves, and an agent to invigorate the circulaｭ
tion of blood and dissolve the stagnant. It was usuｭ
ally used to treat the up.easiness, melancholia, 
pulmonary abscess, sores, swelling and traumatic 
injuries from fals in traditional Chinese medicines. 
Recently, it was reported to show many pharmacolｭ
ogical activities, such as antitumor, uterotonic, 
antagonic actions against PAF receptor, etc.16In the 
process of our study on the variety analysis and 
quality assessment of traditional herbal materials, 
we . paid much attention to those with saponins _as 
their principles, such as Glyccyrhiza uralensis, G. 
inflata, G. glabra,10ｷ 17 Bupleurum scorzonerゆlium,18
B. chinense DC,19 B. smithii var. parvifolium,20 and 
B. smithii Wolff,21 As a part of the ninth five-:-year 
research program for traditional Chinese medicines 
granted by ChinaNational Natural Science Foundaｭ
tion, the quality evaluation and the related of 
Cortex Albizae was carried out in our labora-
tory.22曲25
Separatio~ and isolation of triterpenoid 
saponins from Cortex Albiziae 
95%, 90%, 85%, 75% an~ 60% ethanol solu’ 
tions were preliminarily tested as solvents toｷ extract 
crude total saponins from 50 grams of the crude 
drugs, respectively. The extracts were subjected to 
macroporous resin column chromatography to afｭ
ford to 17.5 g, 14.3 g, 12.フ g, 10.8 g and 11.4 g of 
crude total saponins, respectively.ｷ The. extracts 
were obtained for the largest amount by 95% ethaｭ
nol, accordingly, 95% ethanol was chosen as the 
extraction solvent. Since scores of triterpenoid 
saponins with a relatively high content were found 
to be present in this extract, and they share many 
common structure units, miscellaneous separation 
procedures were thus used for the isolation of 
saponins. Macroporous resins (D101) were used to 
remove s,ugars, proteins, resins and some other 
highly-polar constituents. A white pQwder mainly 
composed of saponins was obtained by decolorizing 
crude saponins usingｷ activated charcoal. The comｭ
bination of Sephadex LH-20 column chromatograｭ
phy, normal phase silica gel chromatography, 
reversed phase C1s silica gel chromatography and 
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Rp-18 semi-preparative and preparative HPLC, 
especially the application of a quaternary solvent 
system composed ormethanol, acetonitrile, tetrahyｭ
drofuran and water, allowed a successful isolation 
of 28 saponins, including 6 pairs of diasteroisomers 
and 5 pairs of position isomers，仕om the crude 
saponin fraction. Meanwhile, a weak ultra-violet 
absorption of Julibrosides at 216 nm derived from 
unsaturated monoterpenic acid moieties allowed a 
convenient detection for these saponins. 26ｷ 27 
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Scheme 1: Structures of Julibrosides from Albizia julibrissin 
No. R1 Rz fu R4 Rs R6 R1 Rs JR.9 .!Rm .!Rn C-6 
5 OH H OH OH S1 H H S3 H Qui R 
6 OH H OH OH S1 H H S3 H Qui s 
7 OH Me OH OH S1 H H s3 H Qui R 
8 OH 恥1e OH OH S1 H H s3 H Qui s 
9 OH H OH OH S1 S3 H H H Qui R 
10 OH H OH OH S1 s3 H H H Qui s 
11 OH Me NHAc OH S1 H H S3 H Qui R 
12 OH 恥1e NHAc OH S1 H H S3 H Qui s 
13 OH H OH H S1 H H S3 H Qui R 
14 OH H OH H S1 H H S3 H Qui s 
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15 OH 島rfe OH H S1 
16 OH 恥1e OH H S1 
17 OH H OH OH S1 
18 OH H OH OH S1 
19 OH H OH OH S1 
20 OH Me NHAc OH S1 
21 OH 民1e NHAc OH S1 
22 OH H OH OH S2 
23 OH H OH OH S21 
24 OH H OH OH S2 
25 OH 乱1e OH OH S1 
26 OH H NHAc OH S1 
27 OH H NHAc OH S1 
28 OH Me NHAc H S1 
29 OH H NHAc OH S1 
30 H H OH OH S1 
31 OH H OH OH S1 
32 OH Me OH OH S1 
33 OH Me Glc B S1 
Structures of triterpenoid saponins from 
Cortex Albiziae 
Triterpenoid saponins are composed of sugars 
and aglycones, i.e. triterpenes. In saponins from A. 
julibrおsin, the aglycone is usually a triterpene with 
a skeleton of oleanolic acid: acacic acid (1 ), except 
for three other sapogenins: 16・deoxy acacic acid 
(2),28 30帽hydroxyl acacic acid (3) and 30・carboxyl
acacic acid ( 4).29 To date, only three Julibrosides 
are revealed to be composed of aglycones 2, 3 and 
4. The aglycones are linked to three sugar chains at 
their C・3, C-21 and C-28 positions in these 
saponins. Few saponin has .been found to be at-:ｭ
tached to C-16 hydroxyl group of the aglycone.29 
The monosaccharide moieties in these saponins 
include B-D-glucopyranosyl， βD-xy lopyranosy 1,
P・D-quinovopyranosyl, B-D-fucopyranosyl, 2-deoxy-
2・acetamido-P-D-glucopyranosyl， α－L-rhamnopyranosyl,
仕L-arabinopyranosyl and α－ L-arabinofuranosy 1.
Besides the above strncture units, esterified 
monoterpenic acids were found to be popular in the 
saponins from A. julibr臼sin. The diversity of 
saponin strnctures in this plant seemed to be mainly 
derived from an alternative configuration at C-6 po” 
sition of the outer monote中enic acid moiety (SJ in 
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Scheme 1) in the substituted ~roup at C-21 site of 
the aglycone,26 different esterification positions of 
the inner P-D-quinovopyranosyl moiety (S1 in 
Scheme 1) in ｷthe substituted group at C” 21 site’ of 
the aglycone, 27 a substitution of acetamido group 
for 2・hydroxyl g~oup of ~－D-glucopyranosyl moiety 
(R.3 in Scheme 1) in C-3 sugar chain,23ｷ 30 .etc. 
However, a sugar chain composed of four sugar 
moieties attached to C-28 position of the aglycone 
was litle subjected to any modification when the 
carboxyl group in C-28 position of the aglycone 
was glycosylated. Although a variety of structural 
modifications were found al over the substituted 
group at the C・21 side chain of the aglycone, a 
monoterpenic acid moiety was showed to be linked 
directly to C-21 site of the aglycone for most of 
Julibrosides. 23-28ｷ 30 
Structural elucidation of triterpenoid 
saponins from Cortex Albiziae 
1. Molecular ions observed m their mass spectra 
The mass spectra for most of Julibrosides were 
recorded on a F AB MS machine in a negative or 
positive mode. In such a case, an interesting pheｭ
nomenon ｷwas observed in F AB mass spectra of 
一／
Julibrosides. The positive F AB mass spectra of 
Julibrosides usually showed _quasi-molecular ion 
peaks at ml左［M+Na+2r, or [M+Na+ ir, other than 
at mlな［M+H]+, [M+Nat or [M+Kt. In order to 
obtain a normal molecular or quasi-molecular ion 
peak, ESI-MS and TOF 恥1S were used to record 
their MS spectra. In case of Julibroside J1, however, 
the quasi-molecular ion peak at ml左 1077.6 [M-2］・
wasｷ observed in its ESI-MS, and the quasiｭ
molecular ion peak at ml左 2195 [M+Kr was obｭ
served in its TOF-MS.26 A possible explanation for 
this quasi-moJecular ion peak at ml乞［M+Na+2]+, or 
[M+Na+ It was derived from an introduction of 
carbon-13 isotope in these saponins, such as 
Julibroside I,31 whose high resolution F AB mass 
spectrum gave a quasi-molecular ion peak at ml左
2179.0342 仰がNat, corresponding to a molecular 
formula of 12C10113CH16204&Na. 
2~ Aglycones 
Upon acidic hydrolysis with 2.0 ｷ M HCl, 
Julibrosides gave their sapogenins. In case of 
Julibroside J1, the major saponin in this plant, its 
aglycone ( acacic acid lactone) was identified by its 
1 H NMR and EIMS data. The acacic acid moiety in 
Julibrosides was well represented by its 13C-NMR 
data, which were subjected to litle variation from 
one to another Julibroside. However, a complete 
elucidation of lD and 2D NMR spectra for these 
saponins revealed a false assignment of carbon-13 
signals for 24-and 25-methyl carbons given in 
many litera印res,23ｷ 24, 31ｷ 32 which was revised asδ 
17.1 and 15.8 ppm, respectively.28 
In case of 16-deoxy acacic acid. moiety (1, 
30),28 marked downfield shifts of 7.1 ppm for C・ 15,
49.1 ppm for C-16, and an upfield shift of 3.0 ppm 
for C-17 were observed in its 13C-NMR spectrum. 
Furthermore, the signals of C-19, C-27, C-18 and 
C-28 undergo downfield shifts of 1.3 ppm, 1.4 ppm, 
and upfield shifts of 0.5 ppm, 0.5 ppm, respecｭ
tively. It is worthwhile to be mentioned that the anｭ
gular methyl proton signal at C・27 position 
displayed a distinct upfield shift of 0.52 ppm, from 
δ1.87 ppm toδ1.3 5 ppm, which afforded a charac ” 
terization of 16-deoxy acacic acid moiety, since few 
, 7 
other proto_n signals could be found nearby in the 
1 H NMR spectra of Julibrosides. 
Generally, an introduction of 30” hydroxyl 
group (3) mainly influences the signals of carbons 
in the E-ring, i.e. C-19, 20, 21, 29 and 30, which 
showed ・4.7 ppm，十4.8 ppm，・2.9 ppm，ー 1.5 ppm 
and +40.5 ppm of chemical shifts in comparison 
with those of acacic acid moiety.29 Similarly, a subｭ
stitution of a carbonyl group for a methyl group at 
C-30 of the aglycone-gives rise to 5.0, 4.4 and 6.4 
ppm of upfield shifts for C-19，ー21 and ・29, respecｭ
tively, and 11.4 ppm of a downfield shift for C-
20.29 
3. Monosaccharideｧ and ｧllgar chains 
Upon acidic hydrolysis of Julibrosides with 
2.0 M HCl, monosaccharides were obtained from 
the hydrolyte, which were dried and subjected to 
derivation with hexamethyldisilazane and trimethyｭ
lchlorosilane in anhydrous pyridine. The 
monosaccharides and their ratios were determined 
by the comparison of these derivatives with stanｭ
dards by GLC methods. 26 
2・Deoxy-2・acetamido・B-D帽glucopyranosyl
moiety was found to be present in many saponins 
isolated 企om Albizia and Acacia species, andｭ
showed good activities toward several cancer cel 
lines.23,3i,3,34 This group is characteristic of its 
carbon-13 signals atδ58.0 ppm for the amination 
carbon， δ170.0 and 24.0 ppm for the acetyl carｭ
bons, also its proton signals atδ2.10 ppm for the 
methyl group， δ8.88 (lH, J = 7.8 Hz) for the amide 
proton. Sometimes, the doublet peak for the amide 
proton appeared as a broad single peak when the 
NMR condition was not functioned well. 35 Eight 
saponins with this moiety were isolated from A. 
julibrissin in our experiment (11, 12~ 20, 21, 26-
29). A comparison of 1H-NMR spectrum of 
Julibroside J1 (5) with that of Julibroside 13 (29) reｭ
vealed that the proton signal of H-23 ｷin 29 underｭ
goes an upfield shift of ca. O.B ppm, from δ1.28 
ppm toδ1.15 ppm, where the 26-methyl protons is 
usually located, which make a distinguish between 
them from a view of methyl proton shapes in their 
proton NMR spectra. 30 A report on the 
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conformation of triperpene saponins in solutions 
pointed out that C-3 sugar chains had the most staｭ
ble conformation among the sugar chains. 36 
Therefore, the flexibility and distortion of C-3 sugar 
chains were greatly confined. When a huge group, 
such as an acetamido group, was introduced around 
the A-ring of the aglycone, the 23 ・methyl group 
was rejected by this space hindrance, resulting in an 
Julibroside J1 
increase of the electron cloud density of 23・methyl
protons, which was theoretically derived from a 
closer distance between H-23 and H・3 calculated by 
Chem3D software 5.0 for Julibroside J3 (29) (2.21) 
than_that for Julibroside J1 (5) (2.45), although the 
distances between H-23 and H~24, H・23 and H・23
for these two compounds did not show marked diι 
ferences (Scheme 2). 37 
Scheme 2: 3D structures of Julibrosides J1 and J11 
The ~－D-xylopyranosyl-(1→2）－~－D-fucopyrano 
syl-(1→6)-P・D-glucopyranosyl-, P-D< ylopyranosyl-
(1→2）－α－L-arabinopyranosy 1-( 1→6)-P・D・白copyranosyl
and P-D-xylopyranosyl-(1 • 2}-13” D-fucopyranosylｭ
(1 → 6）ふdeoxyふacetamido-P-D-glucopyranosyl
moieties were the main types of sugar chains 
glycosylated at 3・hydroxyl group of aglycones. ｷA 
substitution of a P・D-fucopyranosylmoiety for aα－ 
L-arabinopyranosyl moiety was easily recognized by 
a sharp methyl proton signal atδ1.4 7 ppm and one 
more methyl carbon signal atδ17.4 ppm, due to a 
methyl group of the f3-D-fucopyranosyl moiety. 
Interestingly, this substitution was also represented 
by small, but distinct, downfield shifts of 0.80 ppm 
and 0.10 ppm, for the anomeric carbon and proton 
signals of f3-D－~ylopyranosyl moiety, respectively.38 
In several saponins (22-25), a P-D-fucopyranosyl・
monoterpenic acid ester moiety was found to be 
linked to their C-21 side chains. 38ｷ 39 A similar side 
chain was found to be present in saponins isolated 
from the branches of Calliandra anomala.40, 41 It’s 
typical of its anomeric carbon signal between δ 
100.1 and 100.7, where no other peaks were located 
in the BC NMR spectra of Julibrosides. 
4. Absolute configuration of C圃6 in the outer 
monoterpenic acid moiety 
Six p~irs of diastereoisomers: 5 and 6,24ｷ 26 7 
5: 6R 
6:6S 
9 
and 8,37 9 and 10,42 :n and Jl.2,35 13 and 14, 15 and 
16,37 were obtained in our experiment, which apｭ
peared pairwise in their HPLC chromatograms. The 
common difference between a pair of diastereoisomer 
was derived from the absolute configuration of C-6 
position in SJ moiety (Scheme 1 ). In order to eluciｭ
date the absolute configuration of C-6 site in SJ 
moiety, 5 and 6 were hydrolyzed with saturated 
NaHCQ3 in methanol, affording to 5-1 and 6-1 
(Scheme 3), respectively. The products were further 
hydrolyzed with f3-glucosidase at room temperaｭ
知re, giving rise to 5-2 and 6-2, respectively, whose 
optical values were identical with those of ( 6R)ｭ
methiafolic acid and ( 6S)-methiafolic acid. Therefore, 
the absolute . configurations of C-6 position in SJ 
moieties for 5 and 6 were assigned as R and S, re帽
spectively. 
Several plants were reported to contain co任
stituents composed of ｧ3 moiety.32ｷ34,4o,42-49 However, 
most of them only bear a 6R configuration, few 
plants were reported to contain compounds conｭ
sisted of 6R and 6S configurations together.42ｷ44 In 
cases of 5, 7, 9, Jl.Jl., 13 and 15, (6R) and (6S)ｭ
methiafolic acid moieties are present in a comｭ
pound together. 
Saponins 5 and 6 possess markedly different 
BC NMR data due to differences in the S3 moiety. 
A comparisonｷ of the 13C-NMR data of 6 with those 
ふ1: 6R 
6-1: 6S 
0・glucosidase
。九，OMe
HO 
ふ2:6R
6圃2:6S
Scheme 3: Degeneration of Julibrosides Ji and J9 
10 
of ｷ5showed that theｷ ~ignals of C-5 and C・10 sites 
in SJ of 6 undergo a downfield shift of 1.8 ppm and 
an upfield shift of 1.3 ppm, respectively. The simiｭ
lar results were observed for al other five pairs of 
saponins, which were identical with the 13C-NMR 
data of ( 6R)-methiafolic acid and ( 6S)-methiafolic 
acid, which were obtained 企om alkaline hydrolysis 
in H20, followed by ~－glucosidase hydrolysis of 7 
and 8.37 
5. Esterification positions of the inner 8-Dｭ
quinovopyranosyl ~oiety (Sl) 
There are three positions available for 
esterification in the S1 moiety. Most of saponins 
bear S1 moieties esterified at C-4 hydroxyl group, 
three of them (17, 19 and 20) at C-3 hydroxyl 
group, and two of them (9 and 10) at C・2 hydroxyl 
hydroxylation of C・9 in the inner monoterpenic 
acid moiety. When itwas subjected to glycosylation 
with. a quinovose, besides some normal shifts of 
signals due to C・5, -6，圃7，幽8 and ・ 10 carbons of 
SJ moiety, an unordinary but marked shift of a proｭ
ton signal due to H-3 proton of SJ moiety was obｭ
served，合omδ6.32 to 6.04 ppm, which was 
probably attributed to a hindrance effect ascribed to 
an introduction of a huge size of substitution group, 
i.e. quinovose.52 
Biological activities of triterpenoid saponins 
from Cortex Albiziae 
1. Antitumor 
So far, ｷmost of activities reported for 
Julibrosides were related to the cytotoxicity against 
group. Saponins with different esterification posi：.、、 human cancer lines. The -cytotoxicity of ten 
tions demonstrated markedly different chroma- Julibrosides‘(5, 6, 7, 8, 15, 18, 21, 23, 27 and 32) 
tographic properties. When saponins share common 
structural units, they appear successively in Rp-18 
HPLC in the order of C-3, C-4 and C-2 types, such 
as saponins 5, 9 and 19. The spectroscopic difer-ｷ 
ences due to different esterification positions were 
well recognized from their proton and carbon-data. 
Saponins 9 and 10 were characteristic of carbon-13 
signals atδ96.9 ppm, due to the anomeric carbon 
of the S1 moiety.50 1H-"NMR spectra of saponins 
17, 19 and 20 showed a distinct triplet peak atδ 
5.74 ppm due to H-3 proton ｷof the S1 moiety.27ｷ 51 
6. Monoterpenic acid moieties 
When the R4 group was substituted for a hyｭ
droxyl group in a saponin, its polarity increased 
greatly. Although a hydroxymethyl structure unit 
was found to be present in the inner mqnote叩enic
acid moiety for most of saponins, seven of them 
(17, 18, 20, 21, 24; 27 and 32) bear this unit in 
their outer monoterpenic acid moieties, i.e. S3 
group.27.3o,37,52 This hydroxylation greatly shifted 
the signals of olefinic carbons neighboring to C-9, 
however, the signal due to the carbonyl carbon was 
litle changed, despite of its locating nearby. In adｭ
dition, the presence of a free hydroxyl group in C-6 
of S3 moiety was always accompanied with a 
against Bel-7402, KB, BGC and HL-60 human ca任
cer lines were observed by SRB method. Although 
anα－L-arabinofuranosyl-( 1 →4）四m-D-glucopyrano
syl-(1 → 3)]-a-L-rhainnopyranosyl-(1 → 2）－βD­
glucopyranosyl ester . unit and a monoteゅene
quinovopyranosyl moiety were thought to be the 
crucial groupsｷ for cytotoxicity. among this class of 
compounds, 52 two of 10 saponin~， which bear these 
crucial groups, did not showed any marked 
cytotoxicity towards the four human cancer cel 
lines mentioned above at 10.0 micromoles by the 
SRB method. All the Julibrosides tested in our exｭ
periment showed better activity against KB cel line 
than other three human cel lines, and showed no 
marked inhibitory action against HL-60 cel line 
even at 10.0 micromoles. The important role of 2-: 
acetamide group in C-3－~・D-glucopyranosylmoiety 
was revealed by the fact that al the saponins with 
this group showed a good cytotoxicity，白rthermore,
the s甘ongestactivity was demonstrated by this kind 
of saponin. 26ｷ 53 
The antitumour activity of a mixture of 
Julibrosides was observed in vivo. Several groups 
of Swiss rats were inoculated subcutaneously with ｷ 
S1so tumour, then fed orally with normal saline, 
cyclophosphamide and Julibroside mixture, 
respectively. 0. 7, 1. 0 and 1. 8 mg/kg of this mixture 
showed 25.4%, 35.1 % and 40.5% inhibitory action 
against S1so growth, respectively, and the inhibitory 
action of 1.8 mg/kg of this mixture is similar to that 
of 10.0 mg/kg of cycfophosphamide. 54 
Recently, a detailed investigation on the antiｭ
cancer action of two analogues to Julibrosides was 
carried out by Gutterman and his colleagues. 55 
These analogues were named as A vicins D and G 
(Scheme 4), and the struc旬re of Avicin D was elu国
cidated as the same as that of 21, i.e. Julibroside 
J19.3o, 56 The mixture of triterpenoid saponins and 
A vicins were demonstrated to induce apoptosis in 
the Jurkat human T cell line by affecting the 
mitochondrial function. A vicin G induced cytochrome 
c release within 30-120_ min in whole cells and 
within a minute in the cell-free system. Caspase inｭ
hibitors DEVD or zVAD-fmk had no effect on 
cytochrome c release, suggesting the direct action 
of A vicin G on the mitochondria. Activation of 
caspase-3 and total cleavage of poly (ADP-ribose) 
polymerase (P ARP) occurred between 2 and 6 h 
pos杭reatment with Avicins by zVAD-fmk. 
Interestingly, in the treated cells no significant 
changes in the membrane potential preceded or acｭ
companied cytochrome c release. A small decrease 
in the generation of reactive oxygen species (ROS) 
was measured. 
In order to evaluate the ability of A vicins to inｭ
hibit chemically induced mouse skin, carcinogenesis 
vaηring doses of Avicins were applied to. shaved 
Scheme 4: Structures of Avicins D and G 
11 
dorsal skin of SENCAR mice 15 min before appliｭ
cation of 100 nmol of 7, 12-dimethylbenz ［α］ anth開
racene (DMBA) twice a week for 4 weeks 
(complete carcinogenesis model). 57 The dorsal 
skin of a second group of mice was treated with one 
dose of 10 nmol of DMBA. Avicins were then apｭ
plied 15 min before repetitive doses of 2 mg of 
phorbol 12-tetradecanoate 13-acetate (TPA) twice a 
week for 8 weeks (initiation/promotion model). At 
12 weeks, Avicins produced a 70% decrease in the 
number of mice with papillomas and a greater than 
90% reduction in the number of papillomas per 
mouse in both protocols. H was also observed: a 
62% and 74% reduction by Avicins in H-ras mutaｭ
tions at codon 61 in the DMBA and DMBAy TPA 
models, respectively, as well as a significant inhibiｭ
tion of the modified DNA base formation (8・OH­
dG) in both protocols. Marked suppressfon of 
aneuploidy occurred with treatment at 16 weeks in 
the initiation/promotion experiment. These findｭ
ings, when combined with the prqapoptotic propｭ
erty of these compounds and their ability to i凶ibit
hydrogen peroxide (H202) generation, nuclear facｭ
tor-KB (NF-KB) activation, and inducible nitric 
oxide synthase (iNOS) induction reported elseｭ
where, suggest that A vicins could prove exciting in 
reduci~g oxidative and nitrosative stress and 
thereby suppressing the development of human skin 
cancer and other epithelial malignancies. 
The effect of F094 (an A vicin『i mixture) and 
A vicin G was examined on tumor necrosis factor 
(TNF)-induced activation of NF-Td3 in Jurkat cells 
(human T cell leukei:nia).58 Both F094 and Avicin G 
were ｷfound to be potent inhibitors of TNF..:induced 
NF-KB. Treatment of Jurkat cells with Avicin G reｭ
sulted in a much slower accumulation of the p65 
subunit of NF・KB into the nucleus whereas the degｭ
radation of I Td3αwas unaffected. A vicin G alsu imｭ
paired the binding of NF-KB to DNA in in vitro 
binding assays. Treatment of cells with DTT totally 
reversed the Avicin G-induced inhibition of NF-KB 
activity, suggesting that sulfhydryl groups critical 
for NF-KB activation were being affected. A vicin 
G treatment resulted in decreased expression of 
NF-KB幽regulated proteins such as iNOS and 
12 
cyclooxygenase (COX-2). Thus, the AviCins may 
prove important for reducing both oxidative and 
nitrosative celluiar stress and thereby suppressing 
the development of malignancies and related disｭ
eases. Another triterpene saponin mixture, named 
as F035,47 an4 the Avicins markedly inhibited the 
growth of several tumor cell lines with minimum 
growth inhibition in human foreskin fibroblasts, 
mouse fibroblast芦， and immortalized breast epitheｭ
lial cells at similar concentrations. F035 and the 
A vicins induced cell cycle ( G l)a汀estof the human 
MDA-MB-453 breast cancer cel line and apoptosis 
of the Jurkat (T-ceH leukemia) and the MDA-MB・
435 breast cancer cell line. The triterpenoid 
saponins also partially inhibited phosphatidylinositol 
3-kinase activity in Jurkat T cells in a: timeｭ
dependent manner and phosphorylation in the 
downstream protein Akt, whereas no affectｷ. was 
seen on the Ras/mitogen” activated protein kinase 
cascade. These observations as well as other work 
from their previously demonstrating mitochondrial 
perturb~tion, chemoprevention, and inhibition of 
NF占B suggest that triterpenoid sap9nins from A. 
主 victoriae have potential as novel anticancer agents. 
Recent work linking Akt signaling with glucose 
metabolism, stress resistance, and longevity sugｭ
gests other potential applications of these. comｭ
pounds. 
2. Antiinflammatory and antibacterial aCtion 
The antiinflamatory action of a mixture comｭ
posed of Julibrosides was observed. The mouse ear 
edema induced by croton oil was markedly deｭ
creased by spreading this mixture on mouse ears at 
a concentration of 1. 8 ｵg/ml, which is approxiｭ
mately equivalent to that of similar dosage of 
Aspirin. Meanwhile, inhibitory action of a mixture 
of Julibrosides against Staphylococcus aureus, 
Escherichia coli, Pseudomonas aeruginosa, Bacillus 
subtilis was examined. This saponin mixture 
showed a marked inhibitory action against 
Pseudomonas aeruginosa, a moderate strength of 
inhibition against Staphylococcus aureus, but litle 
action against the other two bacteria. 59 
3. Others 
The acute toxicity of total Julibrosides was ex--
amined according to the procedures described in 
Append V of ”Assessment Procedures ｷof New 
Drugs_ in China”. The LDso value of this mixture 
was measured as i .132 g/kg by Bliss method. A biｭ
directional adjustment of a Julibroside mixture was 
observed in the ~plenocyte proliferation of mice, i.e. 
stimulation at low concentration (0.1 ng/ml), inhibiｭ
tion at high concentration (100.0 ng/ml). 59 Cortex 
Albizae is recorded as a sedation agent in Chinese 
Pharmacopoeia, and Julibrosides are itsｷ 問or conｭ
stituents in composition, nevertheless, several reｭ
search groups failed to prove a positive sedative 
activity of Julibroside mixtures, estimated 仕om
their prolonging sleep time of mice following 
sodium pentobarbital anesthesia, mixtures. 22ｷ 60 
Meanwhile, a sedative compound was isolated from 
this medicine, i.e. syringaresinol diglucoside, a 
lignan glucoside, other than a saponin. 61ｷ 62 
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